Clinical Trial Update: Dexmedetomidine as an Adjuvant for Femoral Nerve Block and Functional Recovery After Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating dexmedetomidine as an adjuvant for femoral nerve block to improve functional recovery after total knee arthroplasty has been complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Elderly Orthopedic Surgery Complications
• Total Knee Arthroplasty-related Conditions

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Peking University First Hospital | Conditions: Elderly, Total Knee Arthroplasty | Phase 4 | Status: COMPLETED